2023
DOI: 10.1016/j.bioflm.2023.100129
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(8 citation statements)
references
References 135 publications
0
8
0
Order By: Relevance
“…In chronic P. aeruginosa infections, the typical biofilm lifestyle significantly diminishes the effectiveness of antimicrobial treatments, as it results in inherent tolerance. This tolerance encompasses physical and physiological factors, along with biofilm-specific genes that can temporarily shield against antibiotics, thereby fostering the emergence of resistance [80]. The negatively charged polysaccharides (especially the Pel polysaccharide and alginate of P. aeruginosa) can effectively sequestrate the positively charged aminoglycoside class of antibiotics, such as tobramycin, thus preventing them from penetrating the deeper layers of the biofilm [81].…”
Section: Bacterial Biofilm Resistancementioning
confidence: 99%
“…In chronic P. aeruginosa infections, the typical biofilm lifestyle significantly diminishes the effectiveness of antimicrobial treatments, as it results in inherent tolerance. This tolerance encompasses physical and physiological factors, along with biofilm-specific genes that can temporarily shield against antibiotics, thereby fostering the emergence of resistance [80]. The negatively charged polysaccharides (especially the Pel polysaccharide and alginate of P. aeruginosa) can effectively sequestrate the positively charged aminoglycoside class of antibiotics, such as tobramycin, thus preventing them from penetrating the deeper layers of the biofilm [81].…”
Section: Bacterial Biofilm Resistancementioning
confidence: 99%
“…Due to difficult eradication, these antimicrobial-resistant communities of P. aeruginosa can cause a fatal decline in CF lung function [ 27 , 94 ]. Despite expanding knowledge regarding P. aeruginosa biofilm, developing new alternative therapeutic approaches in clinical practice is required, for instance, nanoparticles, quorum sensing inhibitors (QSI), anti-biofilm compounds, and CRISPR gene editing [ 140 ].…”
Section: Pathogenesis Of P Aeruginosa In Cfmentioning
confidence: 99%
“…In addition, the capability of EPS to limit the penetration of anti-microbial agents allows the minimum inhibitory concentration (MIC) of anti-microbial agents on P. aeruginosa biofilms to be 100-1000 times higher than that required to treat bacterioplankton [17,18]. Biofilms are one of the main factors responsible for the development of resistance to antibiotics in P. aeruginosa [19,20]. Currently, various bacteriostatic agents such as anti-microbial peptides and phages, as well as the related mechanisms, have been extensively studied.…”
Section: Introductionmentioning
confidence: 99%